[Vasoactive substances belonging to the body and pharmacologic agents with peripheral point of application].
D000109:Acetylcholine / Q000502:physiology; D000227:Adenine Nucleotides / Q000502:physiology; D000804:Angiotensin II / Q000502:physiology; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects*; D001920:Bradykinin / Q000502:physiology; D004837:Epinephrine / Q000502:physiology; D006632:Histamine / Q000502:physiology; D006801:Humans; D007609:Kallidin / Q000502:physiology; D009539:Nicotinic Acids / Q000494:pharmacology; D009566:Nitrates / Q000494:pharmacology; D009573:Nitrites / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D009705:Nucleosides / Q000502:physiology; D010208:Papaverine / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014667:Vasopressins / Q000502:physiology
D000227:Adenine Nucleotides; D009539:Nicotinic Acids; D009566:Nitrates; D009573:Nitrites; D009705:Nucleosides; D011687:Purines; D013565:Sympatholytics; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D000804:Angiotensin II; D012701:Serotonin; D007609:Kallidin; D006632:Histamine; D010208:Papaverine; D000109:Acetylcholine; D001920:Bradykinin; D009638:Norepinephrine; D004837:Epinephrine
Vasoaktive köRPEREIGENE Stoffe und Pharmaka mit peripherem Angriffspunkt.